Anticoagulants in heart disease: current status and perspectives.

Anticoagulants in heart disease: current status and perspectives.

Detaylı Bibliyografya
Asıl Yazarlar:	De Caterina, R, Husted, S, Wallentin, L, Agnelli, G, Bachmann, F, Baigent, C, Jespersen, J, Kristensen, S, Montalescot, G, Siegbahn, A, Verheugt, F, Weitz, J
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2007

Benzer Materyaller

Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease.
Yazar:: De Caterina, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.
Yazar:: De Caterina, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.
Yazar:: De Caterina, R, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.
Yazar:: De Caterina, R, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

[Expert consensus document on the use of antiplatelet agents].
Yazar:: Patrono, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.
Yazar:: Patrono, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Antiplatelet agents for the treatment and prevention of atherothrombosis.
Yazar:: Patrono, C, ve diğerleri
Baskı/Yayın Bilgisi: (2011)

[Expert consensus document on the use of antiplatelet agents].
Yazar:: Patrono, C, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Current Status of New Anticoagulants in the Management of Venous Thromboembolism
Yazar:: Roberto C. Montoya, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
Yazar:: Verheugt Freek WA, ve diğerleri
Baskı/Yayın Bilgisi: (2001-05-01)

Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays
Yazar:: Mohammadali Boroumand, ve diğerleri
Baskı/Yayın Bilgisi: (2010-04-01)

Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays
Yazar:: Hamidreza Goodarzynejad, ve diğerleri
Baskı/Yayın Bilgisi: (2010-05-01)

New anticoagulants for the prevention of venous thromboembolism
Yazar:: Cecilia Becattini, ve diğerleri
Baskı/Yayın Bilgisi: (2010-04-01)

Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
Yazar:: Antonio Greco, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Epidemiological data on the use of traditional anticoagulants in cardiovascular disease
Yazar:: Reith, C, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Investigation of the current status of anticoagulant resistance in UK Norway rats by VKORC1 genotyping
Yazar:: Clarke, D. J., ve diğerleri
Baskı/Yayın Bilgisi: (2011-10-01)

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
Yazar:: Rocca, B, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment
Yazar:: К. V. Lobastov, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

Current Anticoagulation Statuses among Older Chinese People with Nonvalvular Atrial Fibrillation
Yazar:: Junrong Jiang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-02-01)

Clinical effects of anticoagulants in suspected acute myocardial infarction - Reply
Yazar:: Collins, R, ve diğerleri
Baskı/Yayın Bilgisi: (1997)

Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome.
Yazar:: Åsa Johansson, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Oral anticoagulation – current knowlegde
Yazar:: Anna Karaś, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
Yazar:: Konstantinos I. Gkarmiris, ve diğerleri
Baskı/Yayın Bilgisi: (2024-04-01)

Comorbidity Differentiation and Risk Stratification in the Elderly Patient with Polypharmacy: A Prospective Primary Care Registry on Oral Anticoagulation Therapy
Yazar:: S van Vugt, ve diğerleri
Baskı/Yayın Bilgisi: (2020-05-01)

CURRENT VIEW ON ANTICOAGULANT AND THROMBOLYTIC TREATMENT OF ACUTE PULMONARY EMBOLISM
Yazar:: G. A. Ignatenko, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

Current status of heart transplantation in Turkey
Yazar:: Tahir Yağdı, ve diğerleri
Baskı/Yayın Bilgisi: (2014-12-01)

Current status of heart failure in China
Yazar:: Xiaotong Cui, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Current Controversies in Lupus Anticoagulant Detection
Yazar:: Gary W. Moore
Baskı/Yayın Bilgisi: (2016-12-01)

Current practice and effects of intravenous anticoagulant therapy in hospitalized acute heart failure patients with sinus rhythm
Yazar:: Hiroki Nakano, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Interaction of food supplement L-carnitine with oral anticoagulant acenocoumarol
Yazar:: HU Bachmann
Baskı/Yayın Bilgisi: (2004-06-01)

Anticoagulation for Pregnant Patients with Mechanical Heart Valves
Yazar:: Srivastava AR, ve diğerleri
Baskı/Yayın Bilgisi: (2007-01-01)

Postpartum anticoagulation in women with mechanical heart valves
Yazar:: Irani RA, ve diğerleri
Baskı/Yayın Bilgisi: (2018-10-01)

Clinical and hemodynamic results of heart valve replacement; hemostasis correction with anticoagulants
Yazar:: G. V. Arkadieva, ve diğerleri
Baskı/Yayın Bilgisi: (2005-06-01)

Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
Yazar:: Sofia Attelind, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

The Current Status of Neuroprotection in Congenital Heart Disease
Yazar:: Kei Kobayashi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Current status of rheumatic heart disease in India
Yazar:: P.C. Negi, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Antidote for new oral anticoagulants - present status
Yazar:: Abhijit S Nair, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants
Yazar:: A. D. Aga, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
Yazar:: Emmanuel J. Favaloro, ve diğerleri
Baskı/Yayın Bilgisi: (2022-02-01)

THE ROLE OF ANTICOAGULATION THERAPY IN PATIENTS WITH PROSTHETIC HEART VALVES
Yazar:: N. A. Shostak, ve diğerleri
Baskı/Yayın Bilgisi: (2016-09-01)